# To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome

> **NCT06388070** · PHASE3 · COMPLETED · sponsor: **Huons Co., Ltd.** · enrollment: 297 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** HA 0.3%
- **DRUG:** Hyalein Mini Eye Drops

## Key facts

- **NCT ID:** NCT06388070
- **Lead sponsor:** Huons Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-20
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-03-21
- **Target enrollment:** 297 (ACTUAL)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06388070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06388070, "To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06388070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*